logo
  • Home
  • News
Menu

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

Home / Stock Analysis / GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A
Article feature image

GC Pharma Announces GreenGene F Approval in China for the Treatment of Haemophilia A

12 Aug Stock Analysis

YONGIN, South Korea–(BUSINESS WIRE)–GC Pharma (006280.KS) today announced the approval of GreenGene F (Beroctocog alfa)

Click here to view the original article.

Tags:
Business Wire, Global
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

stock_market_width_1200_format_jpeg_cff54ff6eb.jpg
+

AEO Stock Analysis: Why American Eagle Outfitters, Inc. is a Trending Stock?

24 Jul Stock Analysis
1-uk-broker-ratings-1.jpg
+

Evaluating The Growth Potential Amid A Competitive Landscape

24 Jul Stock Analysis

recent post

  • stock_market_width_1200_format_jpeg_cff54ff6eb.jpg

    AEO Stock Analysis: Why American Eagle

    Jul 24 2025
  • 6882984aa40ab46d096704cc_68829848a40ab46d09670373_lastImage.png

    Navigating XRP’s Price Resistance: A Guide

    Jul 24 2025
  • Picture1-7.jpg

    Crypto and Blockchain Gaming at the

    Jul 24 2025
  • 68829de69a444dcf7f53e6cf_68829de5942143f374caffdf_lastImage.png

    Ethereum’s Price Movements Are Changing the

    Jul 24 2025
  • vf725-elizabeth-warren.jpg

    Elizabeth Warren Says Trump Is Turning

    Jul 24 2025

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.